We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability (PHATHOM)

Webinar

 
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability (PHATHOM)
 

Who's speaking at this Webinar?

Gül Dölen, PhD
Associate Professor of Neuroscience, The Johns Hopkins University
 

Psychedelics have been used for millennia in both spiritual and medicinal contexts. Recently, a number of clinical successes with psychedelics have generated considerable excitement; nevertheless, mechanisms underlying their therapeutic efficacy are largely unknown.

Dr. Dölen will discuss recent evidence from her lab that MDMA targets an evolutionarily ancient mechanism shared with Octopus (Edsinger and Dolen, Current Biology 2018) and may have its therapeutic effects through its ability to reopen the social reward learning critical period (Nardou, et al., Nature, 2019).


Building on this discovery, Dr. Dölen has initiated the PHATHOM project (Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability; www.phathomproject.org), which aims to test the hypothesis that psychedelic drugs as a class act to reopen multiple critical periods across the brain, and that this property can be harnessed for therapeutic benefit.


During this webinar we will discuss:

  • Therapeutic effects and the mechanism of action of MDMA
  • The PHATHOM project and what it aims to achieve
  • What the future holds for psychedelic drugs as therapeutic agents

 
 
 
Advertisement
 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE